|
|
News Breaks | | | | February 1, 2013 | | 12:40 EDT |  | VRTX | Vertex announces Irish approval for funding of Kalydeco
Vertex Pharmaceuticals announced that the Health Service Executive in the Republic of Ireland will fund Kalydeco, the first medicine to treat the underlying cause of cystic fibrosis, for people ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene. | |
|
News For VRTX From The Last 14 Days Check below for free stories on VRTX the last two weeks. |
|
|
| There are no results for VRTX |
|
|
|
|
|
|
